Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Cytomegalovirus Infection

Free Subscription Articles published in J Virol Retrieve available abstracts of 134 articles: HTML format

Single Articles

March 2021
1. MOMTAZ S, Molina B, Mlera L, Goodrum F, et al
   Cell type-specific biogenesis of novel vesicles containing viral products in human cytomegalovirus infection.
   J Virol. 2021 Mar 24. pii: JVI.02358-20. doi: 10.1128/JVI.02358.
   PubMed     Abstract available
   
   
   
2. FORTE E, Ayaloglu Butun F, Marinaccio C, Schipma MJ, et al
   Epigenetic reprogramming of host and viral genes by Human Cytomegalovirus infection in Kasumi-3 myeloid progenitor cells at early times post-infection.
   J Virol. 2021 Mar 17. pii: JVI.00183-21. doi: 10.1128/JVI.00183.
   PubMed     Abstract available
   
   
   
3. CHOI KY, El-Hamdi N, Hornig J, McGregor A, et al
   Guinea pig cytomegalovirus protective T cell antigen GP83 is a functional pp65 homolog for innate immune evasion and pentamer dependent virus tropism.
   J Virol. 2021 Mar 3. pii: JVI.00324-21. doi: 10.1128/JVI.00324.
   PubMed     Abstract available
   
   
   January 2021
4. YANG B, Yao Y, Wu H, Yang H, et al
   Localization of the WD repeat-containing protein 5 to the Virion Assembly Compartment Facilitates Human Cytomegalovirus Assembly.
   J Virol. 2021 Jan 27. pii: JVI.02101-20. doi: 10.1128/JVI.02101.
   PubMed     Abstract available
   
   
   
5. CRAWFORD LB, Hancock MH, Struthers HM, Streblow DN, et al
   CD34(+) Hematopoietic Progenitor Cell Subsets Exhibit Differential Ability To Maintain Human Cytomegalovirus Latency and Persistence.
   J Virol. 2021;95.
   PubMed     Abstract available
   
   
   December 2020
6. KONIG P, Svrlanska A, Read C, Feichtinger S, et al
   The autophagy-initiating protein kinase ULK1 phosphorylates human cytomegalovirus tegument protein pp28 and regulates efficient virus release.
   J Virol. 2020 Dec 16. pii: JVI.02346-20. doi: 10.1128/JVI.02346.
   PubMed     Abstract available
   
   
   
7. DUNN DM, Rodriguez-Sanchez I, Schafer X, Munger J, et al
   Human Cytomegalovirus Induces the Expression of the AMPKa2 Subunit to Drive Glycolytic Activation and Support Productive Viral Infection.
   J Virol. 2020 Dec 2. pii: JVI.01321-20. doi: 10.1128/JVI.01321.
   PubMed     Abstract available
   
   
   November 2020
8. KUAN MI, Jaeger HK, Balemba OB, O'Dowd JM, et al
   Human cytomegalovirus interactions with the basement membrane protein nidogen 1.
   J Virol. 2020 Nov 11. pii: JVI.01506-20. doi: 10.1128/JVI.01506.
   PubMed     Abstract available
   
   
   September 2020
9. LLOYD MG, Smith NA, Tighe M, Travis KL, et al
   A novel human skin tissue model to study varicella zoster virus and human cytomegalovirus.
   J Virol. 2020 Sep 2. pii: JVI.01082-20. doi: 10.1128/JVI.01082.
   PubMed     Abstract available
   
   
   
10. ALTMAN AM, Miller MJ, Mahmud J, Smith NA, et al
    Human Cytomegalovirus-Induced Autophagy Prevents Necroptosis Of Infected Monocytes.
    J Virol. 2020 Sep 2. pii: JVI.01022-20. doi: 10.1128/JVI.01022.
    PubMed     Abstract available
    
    
    August 2020
11. REDWOOD AJ, Masters LL, Chan B, Leary S, et al
    Repair of an attenuated low passage murine cytomegalovirus bacterial artificial chromosome identifies a novel spliced gene essential for salivary gland tropism.
    J Virol. 2020 Aug 26. pii: JVI.01456-20. doi: 10.1128/JVI.01456.
    PubMed     Abstract available
    
    
    July 2020
12. ALFI O, From I, Yakirevitch A, Drendel M, et al
    Human Nasal Turbinate Tissues in Organ Culture as a Model for Human Cytomegalovirus Infection at the Mucosal Entry Site.
    J Virol. 2020 Jul 29. pii: JVI.01258-20. doi: 10.1128/JVI.01258.
    PubMed     Abstract available
    
    
    
13. KUTLE I, Szymanska-de Wijs KM, Bogdanow B, Cuvalo B, et al
    Murine cytomegalovirus M25 proteins sequester the tumor suppressor protein p53 in nuclear accumulations.
    J Virol. 2020 Jul 29. pii: JVI.00574-20. doi: 10.1128/JVI.00574.
    PubMed     Abstract available
    
    
    
14. CHAILLON A, Nakazawa M, Rawlings SA, Curtin G, et al
    Subclinical CMV and EBV Shedding is associated with increasing HIV DNA Molecular Diversity in Peripheral Blood during Suppressive Antiretroviral Therapy.
    J Virol. 2020 Jul 8. pii: JVI.00927-20. doi: 10.1128/JVI.00927.
    PubMed     Abstract available
    
    
    
15. REUTER N, Kropff B, Schneiderbanger JK, Alt M, et al
    Cell fusion induced by a fusion-active form of human cytomegalovirus glycoprotein B is inhibited by antibodies directed at AD-5 in the ectodomain of gB.
    J Virol. 2020 Jul 8. pii: JVI.01276-20. doi: 10.1128/JVI.01276.
    PubMed     Abstract available
    
    
    
16. KUMAR R, Cruz L, Sandhu PK, Buchkovich NJ, et al
    UL88 Mediates the Incorporation of a Subset of Proteins into the Virion Tegument.
    J Virol. 2020;94.
    PubMed     Abstract available
    
    
    June 2020
17. NUKUI M, Roche KL, Jia J, Fox PL, et al
    Protein S-nitrosylation of Human Cytomegalovirus pp71 inhibits its ability to limit STING antiviral responses.
    J Virol. 2020 Jun 24. pii: JVI.00033-20. doi: 10.1128/JVI.00033.
    PubMed     Abstract available
    
    
    
18. SCHULTZ EP, Lanchy JM, Day LZ, Yu Q, et al
    Specialization for Cell-Free or Cell-to-Cell Spread of BAC-Cloned Human Cytomegalovirus Strains Is Determined by Factors beyond the UL128-131 and RL13 Loci.
    J Virol. 2020;94.
    PubMed     Abstract available
    
    
    
19. STRECK NT, Zhao Y, Sundstrom JM, Buchkovich NJ, et al
    Human Cytomegalovirus Utilizes Extracellular Vesicles to Enhance Virus Spread.
    J Virol. 2020 Jun 10. pii: JVI.00609-20. doi: 10.1128/JVI.00609.
    PubMed     Abstract available
    
    
    
20. MAHMUD J, Miller MJ, Altman AM, Chan GC, et al
    Human Cytomegalovirus Glycoprotein-Initiated Signaling Mediates the Aberrant Activation of Akt.
    J Virol. 2020 Jun 3. pii: JVI.00167-20. doi: 10.1128/JVI.00167.
    PubMed     Abstract available
    
    
    April 2020
21. BRAIT N, Stogerer T, Kalser J, Adler B, et al
    Influence of human cytomegalovirus glycoprotein O polymorphism on the inhibitory effect of soluble forms of trimer- and pentamer-specific entry receptors.
    J Virol. 2020 Apr 29. pii: JVI.00107-20. doi: 10.1128/JVI.00107.
    PubMed     Abstract available
    
    
    
22. LEE MK, Hyeon S, Ahn JH
    Loss of VCP/p97 induced by the human cytomegalovirus transmembrane protein pUL50 and its regulation by a small isoform of pUL50.
    J Virol. 2020 Apr 22. pii: JVI.00110-20. doi: 10.1128/JVI.00110.
    PubMed     Abstract available
    
    
    
23. ZOU HM, Huang ZF, Yang Y, Luo WW, et al
    Human Cytomegalovirus Protein UL94 Targets MITA to Evade Antiviral Immune Response.
    J Virol. 2020 Apr 1. pii: JVI.00022-20. doi: 10.1128/JVI.00022.
    PubMed     Abstract available
    
    
    March 2020
24. THOMAS M, Muller R, Horn G, Bogdanow B, et al
    Phosphosite Analysis of the Cytomegaloviral mRNA Export Factor pUL69 Reveals Serines with Critical Importance for Recruitment of Cellular Proteins Pin1 and UAP56/URH49.
    J Virol. 2020;94.
    PubMed     Abstract available
    
    
    
25. RAK MA, Buehler J, Zeltzer S, Reitsma J, et al
    Erratum for Rak et al., "Human Cytomegalovirus UL135 Interacts with Host Adaptor Proteins To Regulate Epidermal Growth Factor Receptor and Reactivation from Latency".
    J Virol. 2020;94.
    PubMed    
    
    
    
26. SANDHU PK, Buchkovich NJ
    Human Cytomegalovirus Decreases Major Histocompatibility Complex Class II by Regulating Class II Transactivator Transcript Levels in a Myeloid Cell Line.
    J Virol. 2020;94.
    PubMed     Abstract available
    
    
    February 2020
27. NELSON CS, Jenks JA, Pardi N, Goodwin M, et al
    HCMV glycoprotein B nucleoside-modified mRNA vaccine elicits antibody responses with greater durability and breadth than MF59-adjuvanted gB protein immunization.
    J Virol. 2020 Feb 12. pii: JVI.00186-20. doi: 10.1128/JVI.00186.
    PubMed     Abstract available
    
    
    January 2020
28. DAY LZ, Stegmann C, Schultz EP, Lanchy JM, et al
    Polymorphisms in Human Cytomegalovirus gO Exert Epistatic Influences on Cell-Free and Cell-To-Cell Spread, and Antibody Neutralization on gH Epitopes.
    J Virol. 2020 Jan 29. pii: JVI.02051-19. doi: 10.1128/JVI.02051.
    PubMed     Abstract available
    
    
    
29. MURRAY MJ, Bonilla-Medrano NI, Lee QL, Oxenford SJ, et al
    Evasion of a human cytomegalovirus entry inhibitor with potent cysteine reactivity is concomitant with the utilisation of a heparan sulfate proteoglycan independent route of entry.
    J Virol. 2020 Jan 15. pii: JVI.02012-19. doi: 10.1128/JVI.02012.
    PubMed     Abstract available
    
    
    
30. HAN T, Hao H, Sleman SS, Xuan B, et al
    Murine cytomegalovirus protein pM49 interacts with pM95 and is critical for viral late gene expression.
    J Virol. 2020 Jan 2. pii: JVI.01956-19. doi: 10.1128/JVI.01956.
    PubMed     Abstract available
    
    
    December 2019
31. NGUYEN CC, Domma AJ, Zhang H, Kamil JP, et al
    ER reorganization and intracellular retention of CD58 are functionally independent properties of the human cytomegalovirus ER resident glycoprotein UL148.
    J Virol. 2019 Dec 4. pii: JVI.01435-19. doi: 10.1128/JVI.01435.
    PubMed     Abstract available
    
    
    
32. CHIUPPESI F, Nguyen J, Park S, Contreras H, et al
    Correction for Chiuppesi et al., "Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Responses against Human Cytomegalovirus in Mice".
    J Virol. 2019;93.
    PubMed    
    
    
    November 2019
33. COMBS JA, Norton EB, Saifudeen ZR, Honer Zu Bentrup K, et al
    Human Cytomegalovirus Alters Host Cell Mitochondrial Function During Acute Infection.
    J Virol. 2019 Nov 6. pii: JVI.01183-19. doi: 10.1128/JVI.01183.
    PubMed     Abstract available
    
    
    October 2019
34. AGUILAR OA, Sampaio IS, Rahim MMA, Samaniego JD, et al
    Mouse cytomegalovirus m153 protein stabilizes expression of the inhibitory NKR-P1B ligand, Clr-b.
    J Virol. 2019 Oct 9. pii: JVI.01220-19. doi: 10.1128/JVI.01220.
    PubMed     Abstract available
    
    
    September 2019
35. LIU Y, Freed DC, Li L, Tang A, et al
    A Replication Defective Human Cytomegalovirus Vaccine Elicits Humoral Immune Responses Analogous to Those with Natural Infection.
    J Virol. 2019 Sep 11. pii: JVI.00747-19. doi: 10.1128/JVI.00747.
    PubMed     Abstract available
    
    
    
36. CHOI KY, El-Hamdi NS, McGregor A
    Inclusion of the viral pentamer complex in a vaccine design greatly improves protection against congenital cytomegalovirus in the guinea pig model.
    J Virol. 2019 Sep 4. pii: JVI.01442-19. doi: 10.1128/JVI.01442.
    PubMed     Abstract available
    
    
    August 2019
37. LEE JH, Pasquarella JR, Kalejta RF
    Cell Line Models for Human Cytomegalovirus Latency Faithfully Mimic Viral Entry by Macropinocytosis and Endocytosis.
    J Virol. 2019 Aug 7. pii: JVI.01021-19. doi: 10.1128/JVI.01021.
    PubMed     Abstract available
    
    
    
38. XI Y, Harwood S, Wise L, Purdy JG, et al
    Human Cytomegalovirus pUL37x1 is Important to Remodeling of Host Lipid Metabolism.
    J Virol. 2019 Aug 7. pii: JVI.00843-19. doi: 10.1128/JVI.00843.
    PubMed     Abstract available
    
    
    
39. WILSKI NA, Del Casale C, Purwin TJ, Aplin AE, et al
    Murine cytomegalovirus infection of melanoma lesions delays tumor growth by recruiting and re-polarizing monocytic phagocytes in the tumor.
    J Virol. 2019 Aug 2. pii: JVI.00533-19. doi: 10.1128/JVI.00533.
    PubMed     Abstract available
    
    
    July 2019
40. ELIYAHU E, Tirosh O, Dobesova M, Nachshon A, et al
    ROCK1 translocates to the nucleus and inhibits human cytomegalovirus propagation.
    J Virol. 2019 Jul 10. pii: JVI.00453-19. doi: 10.1128/JVI.00453.
    PubMed     Abstract available
    
    
    June 2019
41. SISON SL, O'Brien BS, Johnson AJ, Seminary ER, et al
    Human Cytomegalovirus Disruption of Calcium Signaling in Neural Progenitor Cells and Organoids.
    J Virol. 2019 Jun 19. pii: JVI.00954-19. doi: 10.1128/JVI.00954.
    PubMed     Abstract available
    
    
    
42. BROWN RM, Rana PSJB, Jaeger HK, O'Dowd JM, et al
    Human Cytomegalovirus Compromises Development of Cerebral Organoids.
    J Virol. 2019 Jun 19. pii: JVI.00957-19. doi: 10.1128/JVI.00957.
    PubMed     Abstract available
    
    
    
43. LEHMANN C, Falk JJ, Buscher N, Penner I, et al
    Dense bodies of a gH/gL/UL128-131 pentamer repaired Towne strain of human cytomegalovirus induce an enhanced neutralizing antibody response.
    J Virol. 2019 Jun 12. pii: JVI.00931-19. doi: 10.1128/JVI.00931.
    PubMed     Abstract available
    
    
    May 2019
44. PICARDA G, Ghosh R, McDonald B, Verma S, et al
    Cytomegalovirus evades TRAIL-mediated innate lymphoid cell 1 defenses.
    J Virol. 2019 May 29. pii: JVI.00617-19. doi: 10.1128/JVI.00617.
    PubMed     Abstract available
    
    
    
45. LEE JH, Kalejta RF
    Human Cytomegalovirus Enters the Primary CD34+ Hematopoietic Progenitor Cells where it Establishes Latency by Macropinocytosis.
    J Virol. 2019 May 22. pii: JVI.00452-19. doi: 10.1128/JVI.00452.
    PubMed     Abstract available
    
    
    
46. FARRELL HE, Bruce K, Lawler C, Stevenson PG, et al
    Murine cytomegalovirus spread depends on the infected myeloid cell type.
    J Virol. 2019 May 15. pii: JVI.00540-19. doi: 10.1128/JVI.00540.
    PubMed     Abstract available
    
    
    April 2019
47. CHRISTENSEN-QUICK A, Massanella M, Frick A, Rawlings SA, et al
    Subclinical Cytomegalovirus DNA Is Associated with CD4 T Cell Activation and Impaired CD8 T Cell CD107a Expression in People Living with HIV despite Early Antiretroviral Therapy.
    J Virol. 2019 Apr 24. pii: JVI.00179-19. doi: 10.1128/JVI.00179.
    PubMed     Abstract available
    
    
    
48. READ C, Schauflinger M, Nikolaenko D, Walther P, et al
    Regulation of human cytomegalovirus secondary envelopment by a C-terminal tetra-lysine motif in pUL71.
    J Virol. 2019 Apr 17. pii: JVI.02244-18. doi: 10.1128/JVI.02244.
    PubMed     Abstract available
    
    
    March 2019
49. GELBMANN CB, Kalejta RF
    The membrane-spanning peptide and acidic cluster dileucine sorting motif of UL138 are required to downregulate MRP1 drug transporter function in human cytomegalovirus infected cells.
    J Virol. 2019 Mar 20. pii: JVI.00430-19. doi: 10.1128/JVI.00430.
    PubMed     Abstract available
    
    
    
50. STEGMANN C, Rothemund F, Sampaio KL, Adler B, et al
    The N-terminus of the human cytomegalovirus glycoprotein O is important for binding to the cellular receptor PDGFRalpha.
    J Virol. 2019 Mar 20. pii: JVI.00138-19. doi: 10.1128/JVI.00138.
    PubMed     Abstract available
    
    
    
51. SCHWARTZ M, Stern-Ginossar N
    The Transcriptome of Latent Human Cytomegalovirus.
    J Virol. 2019 Mar 13. pii: JVI.00047-19. doi: 10.1128/JVI.00047.
    PubMed     Abstract available
    
    
    
52. FU YZ, Su S, Zou HM, Guo Y, et al
    Human Cytomegalovirus DNA Polymerase Subunit UL44 Antagonizes Antiviral Immune Responses by Suppressing IRF3- and NF-kappaB-mediated transcription.
    J Virol. 2019 Mar 13. pii: JVI.00181-19. doi: 10.1128/JVI.00181.
    PubMed     Abstract available
    
    
    February 2019
53. SVRLANSKA A, Reichel A, Schilling EM, Scherer M, et al
    A non-canonical function of polycomb repressive complexes promotes human cytomegalovirus lytic DNA replication and serves as a novel cellular target for antiviral intervention.
    J Virol. 2019 Feb 27. pii: JVI.02143-18. doi: 10.1128/JVI.02143.
    PubMed     Abstract available
    
    
    
54. GOODWIN CM, Munger J
    The IkappaB kinases restrict human cytomegalovirus infection.
    J Virol. 2019 Feb 13. pii: JVI.02030-18. doi: 10.1128/JVI.02030.
    PubMed     Abstract available
    
    
    January 2019
55. LIPPOLD S, Braun B, Kruger F, Harms M, et al
    Natural inhibitor of human cytomegalovirus in human seminal plasma.
    J Virol. 2019 Jan 9. pii: JVI.01855-18. doi: 10.1128/JVI.01855.
    PubMed     Abstract available
    
    
    December 2018
56. NELSON CS, Cruz DV, Su M, Xie G, et al
    Intrahost dynamics of human cytomegalovirus variants acquired by seronegative glycoprotein B vaccinees.
    J Virol. 2018 Dec 5. pii: JVI.01695-18. doi: 10.1128/JVI.01695.
    PubMed     Abstract available
    
    
    November 2018
57. MACHALA EA, Avdic S, Stern L, Zajonc DM, et al
    Restriction of human cytomegalovirus infection by galectin-9.
    J Virol. 2018 Nov 28. pii: JVI.01746-18. doi: 10.1128/JVI.01746.
    PubMed     Abstract available
    
    
    
58. KOLB P, Sijmons S, McArdle MR, Taher H, et al
    Identification and functional characterization of a novel Fc gamma-binding glycoprotein in Rhesus Cytomegalovirus.
    J Virol. 2018 Nov 28. pii: JVI.02077-18. doi: 10.1128/JVI.02077.
    PubMed     Abstract available
    
    
    
59. MORRISON KM, Beucler MJ, Campbell EO, White MA, et al
    Development of a primary human cell model for the study of human cytomegalovirus replication and spread within salivary epithelium.
    J Virol. 2018 Nov 7. pii: JVI.01608-18. doi: 10.1128/JVI.01608.
    PubMed     Abstract available
    
    
    
60. YUNIS J, Farrell HE, Bruce K, Lawler C, et al
    Murine Cytomegalovirus glycoprotein O promotes epithelial cell infection in vivo.
    J Virol. 2018 Nov 7. pii: JVI.01378-18. doi: 10.1128/JVI.01378.
    PubMed     Abstract available
    
    
    October 2018
61. ZIMMERMANN C, Buscher N, Krauter S, Kramer N, et al
    The abundant tegument protein pUL25 of human cytomegalovirus prevents proteasomal degradation of pUL26 and supports its suppression of ISGylation.
    J Virol. 2018 Oct 3. pii: JVI.01180-18. doi: 10.1128/JVI.01180.
    PubMed     Abstract available
    
    
    
62. HASAN MH, Davis LE, Bollavarapu RK, Mitra D, et al
    Dynamin is required for efficient cytomegalovirus maturation and envelopment.
    J Virol. 2018 Oct 3. pii: JVI.01418-18. doi: 10.1128/JVI.01418.
    PubMed     Abstract available
    
    
    September 2018
63. HOU W, Cruz-Cosme R, Wen F, Ahn JH, et al
    Expression of Human Cytomegalovirus IE1 Leads to Accumulation of Mono-SUMOylated PML That Is Protected from Degradation by HSV-1 ICP0.
    J Virol. 2018 Sep 26. pii: JVI.01452-18. doi: 10.1128/JVI.01452.
    PubMed     Abstract available
    
    
    
64. JAMES S, Donato D, Pouliquen JF, Ruiz-Garcia M, et al
    DNA Polymerase Sequences of New World Monkey Cytomegaloviruses: Another Molecular Marker with Which To Infer Platyrrhini Systematics.
    J Virol. 2018;92.
    PubMed     Abstract available
    
    
    
65. BOECK JM, Stowell GA, O'Connor CM, Spencer JV, et al
    The human cytomegalovirus US27 gene product constitutively activates antioxidant response element (ARE)-mediated transcription through Gbetagamma, phosphoinositide 3-kinase (PI3K), and nuclear respiratory factor 1 (NRF-1).
    J Virol. 2018 Sep 12. pii: JVI.00644-18. doi: 10.1128/JVI.00644.
    PubMed     Abstract available
    
    
    
66. DASSA L, Seidel E, Oiknine-Djian E, Yamin R, et al
    The Human Cytomegalovirus Protein UL148A Downregulates the NK Cell-Activating Ligand MICA To Avoid NK Cell Attack.
    J Virol. 2018;92.
    PubMed     Abstract available
    
    
    August 2018
67. LIU J, Jardetzky TS, Chin AL, Johnson DC, et al
    The human cytomegalovirus trimer and pentamer promote sequential steps in entry into epithelial and endothelial cells at cell surfaces and endosomes.
    J Virol. 2018 Aug 15. pii: JVI.01336-18. doi: 10.1128/JVI.01336.
    PubMed     Abstract available
    
    
    
68. ROCHE KL, Nukui M, Krishna BA, O'Connor CM, et al
    Selective 4-thiouracil labeling of RNA transcripts within latently infected cells after infection with human cytomegalovirus expressing functional uracil phosphoribosyltransferase.
    J Virol. 2018 Aug 8. pii: JVI.00880-18. doi: 10.1128/JVI.00880.
    PubMed     Abstract available
    
    
    
69. RAK MA, Buehler J, Zeltzer S, Reitsma J, et al
    Human Cytomegalovirus UL135 Interacts with Host Adaptor Proteins to Regulate Epidermal Growth Factor Receptor and Reactivation from Latency.
    J Virol. 2018 Aug 8. pii: JVI.00919-18. doi: 10.1128/JVI.00919.
    PubMed     Abstract available
    
    
    
70. PERMAR SR, Schleiss MR, Plotkin SA
    Reply to Gantt et al., "Higher Expectations for a Vaccine To Prevent Congenital Cytomegalovirus Infection".
    J Virol. 2018;92.
    PubMed    
    
    
    
71. GANTT S, Marchant A, Boppana SB
    Higher Expectations for a Vaccine To Prevent Congenital Cytomegalovirus Infection.
    J Virol. 2018;92.
    PubMed    
    
    
    
72. KIENER R, Fleischmann M, Wiegand MA, Lemmermann NAW, et al
    Efficient Delivery of Human Cytomegalovirus T Cell Antigens by Attenuated Sendai Virus Vectors.
    J Virol. 2018;92.
    PubMed     Abstract available
    
    
    July 2018
73. SIDDIQUEY MNA, Zhang H, Nguyen CC, Domma AJ, et al
    The human cytomegalovirus ER resident glycoprotein UL148 activates the unfolded protein response.
    J Virol. 2018 Jul 25. pii: JVI.00896-18. doi: 10.1128/JVI.00896.
    PubMed     Abstract available
    
    
    
74. PAUTASSO S, Galitska G, Dell'Oste V, Biolatti M, et al
    Evasion Strategy of Human Cytomegalovirus to Escape Interferon-beta-Induced APOBEC3G Editing Activity.
    J Virol. 2018 Jul 25. pii: JVI.01224-18. doi: 10.1128/JVI.01224.
    PubMed     Abstract available
    
    
    
75. CHIUPPESI F, Nguyen J, Park S, Contreras H, et al
    Multi-Antigenic Modified Vaccinia Ankara Vaccine Vectors to Elicit Potent Humoral and Cellular Immune Reponses Against Human Cytomegalovirus in Mice.
    J Virol. 2018 Jul 25. pii: JVI.01012-18. doi: 10.1128/JVI.01012.
    PubMed     Abstract available
    
    
    
76. LE-TRILLING VTK, Wohlgemuth K, Ruckborn MU, Jagnjic A, et al
    STAT2-Dependent Immune Responses Ensure Host Survival despite the Presence of a Potent Viral Antagonist.
    J Virol. 2018;92.
    PubMed     Abstract available
    
    
    
77. PAN D, Han T, Tang S, Xu W, et al
    Murine Cytomegalovirus Protein pM91 Interacts with pM79 and Is Critical for Viral Late Gene Expression.
    J Virol. 2018 Jul 11. pii: JVI.00675-18. doi: 10.1128/JVI.00675.
    PubMed     Abstract available
    
    
    
78. NGUYEN CC, Siddiquey MNA, Zhang H, Li G, et al
    Human cytomegalovirus tropism modulator UL148 interacts with SEL1L, a cellular factor that governs ER-associated degradation of the viral envelope glycoprotein, gO.
    J Virol. 2018 Jul 11. pii: JVI.00688-18. doi: 10.1128/JVI.00688.
    PubMed     Abstract available
    
    
    
79. CHIEN H, Alston CI, Dix RD
    Suppressor of Cytokine Signaling (SOCS)1 and SOCS3 Are Stimulated Within the Eye During Experimental Murine Cytomegalovirus Retinitis in Mice With Retrovirus-Induced Immunosuppression.
    J Virol. 2018 Jul 5. pii: JVI.00526-18. doi: 10.1128/JVI.00526.
    PubMed     Abstract available
    
    
    June 2018
80. WU CC, Jiang X, Wang XZ, Liu XJ, et al
    Human Cytomegalovirus Immediate-Early 1 Protein Causes Loss of SOX2 from Neural Progenitor Cells by Trapping Unphosphorylated STAT3 in the Nucleus.
    J Virol. 2018 Jun 27. pii: JVI.00340-18. doi: 10.1128/JVI.00340.
    PubMed     Abstract available
    
    
    
81. MARIAME B, Kappler-Gratias S, Kappler M, Balor S, et al
    Real-time visualization and quantification of human Cytomegalovirus replication in living cells using the ANCHOR DNA labeling technology.
    J Virol. 2018 Jun 27. pii: JVI.00571-18. doi: 10.1128/JVI.00571.
    PubMed     Abstract available
    
    
    May 2018
82. WENG C, Lee D, Gelbmann CB, Van Sciver N, et al
    Human cytomegalovirus productively replicates in vitro in undifferentiated oral epithelial cells.
    J Virol. 2018 May 30. pii: JVI.00903-18. doi: 10.1128/JVI.00903.
    PubMed     Abstract available
    
    
    
83. LEE MK, Kim YJ, Kim YE, Han TH, et al
    Transmembrane protein pUL50 of human cytomegalovirus inhibits ISGylation by downregulating UBE1L.
    J Virol. 2018 May 9. pii: JVI.00462-18. doi: 10.1128/JVI.00462.
    PubMed     Abstract available
    
    
    
84. ZHANG L, Zhou M, Stanton R, Kamil J, et al
    Expression levels of glycoprotein O (gO) vary between strains of human cytomegalovirus, influencing the assembly of gH/gL complexes and virion infectivity.
    J Virol. 2018 May 9. pii: JVI.00606-18. doi: 10.1128/JVI.00606.
    PubMed     Abstract available
    
    
    
85. REICHEL A, Stilp AC, Scherer M, Reuter N, et al
    The chromatin remodeling factor SPOC1 acts as a cellular restriction factor against human cytomegalovirus by repressing the major immediate-early promoter.
    J Virol. 2018 May 9. pii: JVI.00342-18. doi: 10.1128/JVI.00342.
    PubMed     Abstract available
    
    
    
86. CHAUMORCEL M, Lussignol M, Mouna L, Cavignac Y, et al
    Correction for Chaumorcel et al., "The Human Cytomegalovirus Protein TRS1 Inhibits Autophagy via Its Interaction with Beclin 1".
    J Virol. 2018;92.
    PubMed    
    
    
    April 2018
87. SUN Y, Bao Q, Xuan B, Xu W, et al
    Human Cytomegalovirus Protein pUL38 Prevents Premature Cell Death by Binding to Ubiquitin-specific Protease 24 and Regulating Iron Metabolism.
    J Virol. 2018 Apr 25. pii: JVI.00191-18. doi: 10.1128/JVI.00191.
    PubMed     Abstract available
    
    
    
88. SANTOS ROCHA C, Hirao LA, Weber MG, Mendez-Lagares G, et al
    Subclinical cytomegalovirus infection associates with altered host immunity, gut microbiota and vaccine responses.
    J Virol. 2018 Apr 18. pii: JVI.00167-18. doi: 10.1128/JVI.00167.
    PubMed     Abstract available
    
    
    February 2018
89. PEREZ-CARMONA N, Martinez-Vicente P, Farre D, Gabaev I, et al
    A prominent role of the human cytomegalovirus UL8 glycoprotein restraining pro-inflammatory cytokine production by myeloid cells at late times during infection.
    J Virol. 2018 Feb 21. pii: JVI.02229-17. doi: 10.1128/JVI.02229.
    PubMed     Abstract available
    
    
    
90. MASCHKOWITZ G, Gartner S, Hofmann-Winkler H, Fickenscher H, et al
    Interaction of human cytomegalovirus tegument proteins ppUL35 and ppUL35A with Sorting Nexin 5 regulates glycoprotein B (gpUL55) localization.
    J Virol. 2018 Feb 14. pii: JVI.00013-18. doi: 10.1128/JVI.00013.
    PubMed     Abstract available
    
    
    
91. YANG B, Liu XJ, Yao Y, Jiang X, et al
    WDR5 Facilitates Human Cytomegalovirus Replication by Promoting Capsid Nuclear Egress.
    J Virol. 2018 Feb 7. pii: JVI.00207-18. doi: 10.1128/JVI.00207.
    PubMed     Abstract available
    
    
    January 2018
92. AREND KC, Lenarcic EM, Moorman NJ
    The 5' Untranslated Region of the Major Immediate Early mRNA is Necessary for Efficient Human Cytomegalovirus Replication.
    J Virol. 2018 Jan 17. pii: JVI.02128-17. doi: 10.1128/JVI.02128.
    PubMed     Abstract available
    
    
    
93. PERMAR SR, Schleiss MR, Plotkin SA
    Advancing our understanding of protective maternal immunity as a guide for development of vaccines to reduce congenital cytomegalovirus infections.
    J Virol. 2018 Jan 17. pii: JVI.00030-18. doi: 10.1128/JVI.00030.
    PubMed     Abstract available
    
    
    
94. MUKHOPADHYAY R, Venkatadri R, Katsnelson J, Arav-Boger R, et al
    Digitoxin suppresses human cytomegalovirus replication via Na(+), K(+)/ATPase alpha1 subunit-dependent AMPK and autophagy activation.
    J Virol. 2018 Jan 10. pii: JVI.01861-17. doi: 10.1128/JVI.01861.
    PubMed     Abstract available
    
    
    
95. WILKIE AR, Sharma M, Pesola JM, Ericsson M, et al
    A role for myosin Va in human cytomegalovirus nuclear egress.
    J Virol. 2018 Jan 3. pii: JVI.01849-17. doi: 10.1128/JVI.01849.
    PubMed     Abstract available
    
    
    December 2017
96. BIOLATTI M, Dell'Oste V, Pautasso S, Gugliesi F, et al
    The Human Cytomegalovirus Tegument Protein pp65 (pUL83) Dampens Type I Interferon Production by Inactivating the DNA Sensor cGAS without Affecting STING.
    J Virol. 2017 Dec 20. pii: JVI.01774-17. doi: 10.1128/JVI.01774.
    PubMed     Abstract available
    
    
    
97. CHILD SJ, Hickson SE, Bayer A, Malouli D, et al
    Antagonism of the protein kinase R pathway in human cells by rhesus cytomegalovirus.
    J Virol. 2017 Dec 20. pii: JVI.01793-17. doi: 10.1128/JVI.01793.
    PubMed     Abstract available
    
    
    
98. CLARK AE, Sabalza M, Gordts PLSM, Spector DH, et al
    Human Cytomegalovirus Replication is Inhibited by the Autophagy-Inducing Compounds Trehalose and SMER28 Through Distinctively Different Mechanisms.
    J Virol. 2017 Dec 13. pii: JVI.02015-17. doi: 10.1128/JVI.02015.
    PubMed     Abstract available
    
    
    
99. TU CC, Arnolds KL, O'Connor CM, Spencer JV, et al
    Human Cytomegalovirus UL111A and US27 gene products enhance the CXCL12/CXCR4 signaling axis via distinct mechanisms.
    J Virol. 2017 Dec 13. pii: JVI.01981-17. doi: 10.1128/JVI.01981.
    PubMed     Abstract available
    
    
    
100. PEREZ KJ, Martinez FP, Cosme-Cruz R, Perez-Crespo NM, et al
     Correction for Perez et al., "A Short cis-Acting Motif in the M112-113 Promoter Region Is Essential for IE3 To Activate M112-113 Gene Expression and Is Important for Murine Cytomegalovirus Replication".
     J Virol. 2017;91.
     PubMed    
     
     
     November 2017
101. WU Z, Qin R, Wang L, Bosso M, et al
     Human Cytomegalovirus Particles Treated with Specific Antibodies Induce Intrinsic and Adaptive but Not Innate Immune Responses.
     J Virol. 2017;91.
     PubMed     Abstract available
     
     
     October 2017
102. KASMAPOUR B, Kubsch T, Rand U, Eiz-Vesper B, et al
     Myeloid dendritic cells repress human cytomegalovirus gene expression and spread by releasing interferon-unrelated soluble antiviral factors.
     J Virol. 2017 Oct 18. pii: JVI.01138-17. doi: 10.1128/JVI.01138.
     PubMed     Abstract available
     
     
     
103. DIETZ AN, Villinger C, Becker S, Frick M, et al
     A tyrosine-based trafficking motif of the tegument protein pUL71 is crucial for human cytomegalovirus secondary envelopment.
     J Virol. 2017 Oct 18. pii: JVI.00907-17. doi: 10.1128/JVI.00907.
     PubMed     Abstract available
     
     
     
104. HENSEL MT, Peng T, Cheng A, De Rosa SC, et al
     Selective Expression of CCR10 and CXCR3 by Circulating Human Herpes Simplex Virus-Specific CD8 T Cells.
     J Virol. 2017;91.
     PubMed     Abstract available
     
     
     September 2017
105. WEISBLUM Y, Oiknine-Djian E, Zakay-Rones Z, Vorontsov O, et al
     APOBEC3A is Upregulated by Human Cytomegalovirus in the Maternal-Fetal Interface, Acting as an Innate Anti-HCMV Effector.
     J Virol. 2017 Sep 27. pii: JVI.01296-17. doi: 10.1128/JVI.01296.
     PubMed     Abstract available
     
     
     
106. GANTT S, Mayer BT, Schiffer JT
     Reply to "Early Stochastic Dynamics in Human Cytomegalovirus Infection".
     J Virol. 2017;91.
     PubMed    
     
     
     
107. WODARZ D, Rodriguez-Brenes I
     Early Stochastic Dynamics in Human Cytomegalovirus Infection.
     J Virol. 2017;91.
     PubMed    
     
     
     
108. VERMA S, Weiskopf D, Gupta A, McDonald B, et al
     Erratum for Verma et al., "Cytomegalovirus-Specific CD4 T Cells Are Cytolytic and Mediate Vaccine Protection".
     J Virol. 2017;91.
     PubMed    
     
     
     August 2017
109. BRITT WJ
     Congenital Human Cytomegalovirus Infection and the Enigma of Maternal Immunity.
     J Virol. 2017;91.
     PubMed     Abstract available
     
     
     June 2017
110. WESTDORP KN, Sand A, Moorman NJ, Terhune SS, et al
     Cytomegalovirus Late Protein pUL31 Alters pre-rRNA Expression and Nuclear Organization during Infection.
     J Virol. 2017 Jun 28. pii: JVI.00593-17. doi: 10.1128/JVI.00593.
     PubMed     Abstract available
     
     
     
111. SCHOMMARTZ T, Tang J, Brost R, Brune W, et al
     Differential requirement of human cytomegalovirus UL112-113 protein isoforms for viral replication.
     J Virol. 2017 Jun 21. pii: JVI.00254-17. doi: 10.1128/JVI.00254.
     PubMed     Abstract available
     
     
     
112. HAN D, Byun SH, Kim J, Kwon M, et al
     Human cytomegalovirus IE2 protein disturbs brain development by dysregulating neural stem cell maintenance and the polarization of migrating neurons.
     J Virol. 2017 Jun 14. pii: JVI.00799-17. doi: 10.1128/JVI.00799.
     PubMed     Abstract available
     
     
     May 2017
113. BIANCO C, Mohr I
     Restriction of Human Cytomegalovirus Replication by ISG15, a Host Effector Regulated by cGAS-STING Double-Stranded-DNA Sensing.
     J Virol. 2017;91.
     PubMed     Abstract available
     
     
     April 2017
114. SELEME MC, Kosmac K, Jonjic S, Britt WJ, et al
     Tumor Necrosis Factor Alpha-Induced Recruitment of Inflammatory Mononuclear Cells Leads to Inflammation and Altered Brain Development in Murine Cytomegalovirus-Infected Newborn Mice.
     J Virol. 2017;91.
     PubMed     Abstract available
     
     
     
115. MAYER BT, Krantz EM, Swan D, Ferrenberg J, et al
     Transient oral human cytomegalovirus infections indicate inefficient viral spread from very few initially infected cells.
     J Virol. 2017 Apr 5. pii: JVI.00380-17. doi: 10.1128/JVI.00380.
     PubMed     Abstract available
     
     
     
116. CUI X, Freed DC, Wang D, Qiu P, et al
     Impact of antibodies and strain polymorphisms on cytomegalovirus entry and spread in fibroblasts and epithelial cells.
     J Virol. 2017 Apr 5. pii: JVI.01650-16. doi: 10.1128/JVI.01650.
     PubMed     Abstract available
     
     
     March 2017
117. NEUBER S, Wagner K, Goldne T, Lischka P, et al
     Mutual Interplay between the Human Cytomegalovirus Terminase Subunits pUL51, pUL56, and pUL89 promotes Terminase Complex Formation.
     J Virol. 2017 Mar 29. pii: JVI.02384-16. doi: 10.1128/JVI.02384.
     PubMed     Abstract available
     
     
     
118. LUGANINI A, Cavaletto N, Raimondo S, Geuna S, et al
     Loss of the Human Cytomegalovirus US16 Protein Abrogates Virus Entry into Endothelial and Epithelial Cells by Reducing the Virion Content of the Pentamer.
     J Virol. 2017 Mar 22. pii: JVI.00205-17. doi: 10.1128/JVI.00205.
     PubMed     Abstract available
     
     
     
119. JACKSON SE, Sedikides GX, Mason GM, Okecha G, et al
     Human Cytomegalovirus (HCMV)-Specific CD4+ T Cells Are Polyfunctional and Can Respond to HCMV-Infected Dendritic Cells In Vitro.
     J Virol. 2017;91.
     PubMed     Abstract available
     
     
     
120. REUTER N, Schilling EM, Scherer M, Muller R, et al
     The ND10 component promyelocytic leukemia protein acts as an E3 ligase for SUMOylation of the major immediate-early protein IE1 of human cytomegalovirus.
     J Virol. 2017 Mar 1. pii: JVI.02335-16. doi: 10.1128/JVI.02335.
     PubMed     Abstract available
     
     
     
121. RIOU R, Bressollette-Bodin C, Boutoille D, Gagne K, et al
     Severe Symptomatic Primary Human Cytomegalovirus Infection despite Effective Innate and Adaptive Immune Responses.
     J Virol. 2017;91.
     PubMed     Abstract available
     
     
     
122. KIM JH, Collins-McMillen D, Buehler JC, Goodrum FD, et al
     Human Cytomegalovirus Requires Epidermal Growth Factor Receptor Signaling To Enter and Initiate the Early Steps in the Establishment of Latency in CD34+ Human Progenitor Cells.
     J Virol. 2017;91.
     PubMed     Abstract available
     
     
     January 2017
123. HA S, Li F, Troutman MC, Freed DC, et al
     Neutralization of Diverse Human Cytomegalovirus Strains Conferred by Antibodies Targets Viral gH/gL/pUL128-131 Pentameric Complex.
     J Virol. 2017 Jan 11. pii: JVI.02033-16. doi: 10.1128/JVI.02033.
     PubMed     Abstract available
     
     
     
124. CHIUPPESI F, Kaltcheva T, Zhuo M, Barry PA, et al
     Identification of a Continuous Neutralizing Epitope within UL128 of Human Cytomegalovirus.
     J Virol. 2017 Jan 11. pii: JVI.01857-16. doi: 10.1128/JVI.01857.
     PubMed     Abstract available
     
     
     
125. CRUZ L, Streck NT, Ferguson K, Desai T, et al
     Potent Inhibition of Human Cytomegalovirus by Modulation of Cellular SNARE Syntaxin 5.
     J Virol. 2016;91.
     PubMed     Abstract available
     
     
     
126. STEGMANN C, Abdellatif ME, Laib Sampaio K, Walther P, et al
     Importance of Highly Conserved Peptide Sites of Human Cytomegalovirus gO for Formation of the gH/gL/gO Complex.
     J Virol. 2016;91.
     PubMed     Abstract available
     
     
     December 2016
127. RENZETTE N, Pfeifer SP, Matuszewski S, Kowalik TF, et al
     On the analysis of intra-host and inter-host viral populations: human cytomegalovirus as a case study of pitfalls and expectations.
     J Virol. 2016 Dec 14. pii: JVI.01976.
     PubMed     Abstract available
     
     
     
128. VINCENT HA, Ziehr B, Moorman NJ
     Mechanism of PKR Inhibition by Human Cytomegalovirus pTRS1.
     J Virol. 2016 Dec 14. pii: JVI.01574.
     PubMed     Abstract available
     
     
     
129. WEISBLUM Y, Oiknine-Djian E, Vorontsov OM, Haimov-Kochman R, et al
     Zika virus infects early- and mid-gestation human maternal-decidual tissues, inducing distinct innate tissue responses in the maternal-fetal interface.
     J Virol. 2016 Dec 14. pii: JVI.01905.
     PubMed     Abstract available
     
     
     November 2016
130. SCHILLING EM, Scherer M, Reuter N, Schweininger J, et al
     The human cytomegalovirus IE1 protein antagonizes PML nuclear body mediated intrinsic immunity via the inhibition of PML de novo SUMOylation.
     J Virol. 2016 Nov 30. pii: JVI.02049.
     PubMed     Abstract available
     
     
     
131. WANG Y, Mao L, Kankanala J, Wang Z, et al
     Inhibition of Human Cytomegalovirus pUL89 Terminase Subunit Blocks Virus Replication and Genome Cleavage.
     J Virol. 2016 Nov 23. pii: JVI.02152.
     PubMed     Abstract available
     
     
     
132. PAN X, Li XJ, Liu XJ, Yuan H, et al
     Correction for Pan et al., Later Passages of Neural Progenitor Cells from Neonatal Brain Are More Permissive for Human Cytomegalovirus Infection.
     J Virol. 2016;90:10431-10433.
     PubMed    
     
     
     
133. CHE JW, Daniels KA, Selin LK, Welsh RM, et al
     Heterologous immunity and persistent murine cytomegalovirus infection.
     J Virol. 2016 Nov 2. pii: JVI.01386.
     PubMed     Abstract available
     
     
     September 2016
134. COHEN T, Williams JD, Opperman TJ, Sanchez R, et al
     Convallatoxin-induced reduction of methionine import effectively inhibits human cytomegalovirus infection and replication.
     J Virol. 2016 Sep 21. pii: JVI.01050.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Cytomegalovirus Infection is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: